Alabama HB 127: Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.

Status: Read for the first time and referred to the House Committee on Health (as of 2026-01-13)

State: Alabama · Session: 2026rs · Bill: HB 127

Subjects: Occupational Licensing Boards

Sponsors: Brown (C)

View Alabama HB 127 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.